APO Research
Talk to an analyst

APO RESEARCH · REPORT

Life Sciences Transactions Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Life Sciences Transactions Service Market Outlook and Growth Opportunities 2026

21 December 2025205 pages

Choose your research edition.

Industry ResearchLife Sciences Transactions Service Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Life Sciences Transactions Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Life Sciences Transactions Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Life Sciences Transactions Service Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Life Sciences Transactions Service Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Life Sciences Transactions Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Life Sciences Transactions Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Life Sciences Transactions Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Life Sciences Transactions Service market include A&L Goodbody, Arnold & Porter, Baker McKenzie, Covington, DLA Piper, HaysMac, Holland & Knight, Kirkland & Ellis LLP and L.E.K. Consulting, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Life Sciences Transactions Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Life Sciences Transactions Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Life Sciences Transactions Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Life Sciences Transactions Service market.

Life Sciences Transactions Service Segment by Company

A&L Goodbody

Arnold & Porter

Baker McKenzie

Covington

DLA Piper

HaysMac

Holland & Knight

Kirkland & Ellis LLP

L.E.K. Consulting

Morgan Lewis

Osborne Clarke

Pharma Bio Source

Pinnacle

Reed Smith LLP

RNA Advisors

Sidley Austin

Tenthpin

Troutman Pepper Locke

WilmerHale

Life Sciences Transactions Service Segment by Type

Intellectual Property Licensing Transactions

Product Asset Transactions

Equity Mergers and Acquisitions

Other

Life Sciences Transactions Service Segment by Application

Biopharmaceuticals and Innovative Therapies

Medical Devices and Diagnostics

Contract Research, Development, and Manufacturing Organizations

Digital Health and Healthcare Services

Others

Life Sciences Transactions Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Life Sciences Transactions Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Life Sciences Transactions Service key companies, revenue, market share, and recent developments.

3. To split the Life Sciences Transactions Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Life Sciences Transactions Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Life Sciences Transactions Service significant trends, drivers, influence factors in global and regions.

6. To analyze Life Sciences Transactions Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life Sciences Transactions Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Life Sciences Transactions Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life Sciences Transactions Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Life Sciences Transactions Service industry.

Chapter 3: Detailed analysis of Life Sciences Transactions Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Life Sciences Transactions Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Life Sciences Transactions Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Life Sciences Transactions Service Industry Trends Table 2. Life Sciences Transactions Service Industry Drivers Table 3. Life Sciences Transactions Service Industry Opportunities and Challenges Table 4. Life Sciences Transactions Service Industry Restraints Table 5. Global Life Sciences Transactions Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Life Sciences Transactions Service Revenue Share by Company (2021-2026) Table 7. Global Life Sciences Transactions Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Life Sciences Transactions Service Key Company Manufacturing Base & Headquarters Table 9. Global Life Sciences Transactions Service Company, Product Type & Application Table 10. Global Life Sciences Transactions Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Life Sciences Transactions Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Intellectual Property Licensing Transactions Table 15. Significant Companies of Product Asset Transactions Table 16. Significant Companies of Equity Mergers and Acquisitions Table 17. Significant Companies of Other Table 18. Global Life Sciences Transactions Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Life Sciences Transactions Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Life Sciences Transactions Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Life Sciences Transactions Service Sales Value Share by Type (2021-2026) Table 22. Global Life Sciences Transactions Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Biopharmaceuticals and Innovative Therapies Table 24. Significant Companies of Medical Devices and Diagnostics Table 25. Significant Companies of Contract Research, Development, and Manufacturing Organizations Table 26. Significant Companies of Digital Health and Healthcare Services Table 27. Significant Companies of Others Table 28. Global Life Sciences Transactions Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Life Sciences Transactions Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Life Sciences Transactions Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Life Sciences Transactions Service Sales Value Share by Application (2021-2026) Table 32. Global Life Sciences Transactions Service Sales Value Share by Application (2027-2032) Table 33. Global Life Sciences Transactions Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Life Sciences Transactions Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Life Sciences Transactions Service Sales Value Share by Region (2021-2026) Table 36. Global Life Sciences Transactions Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Life Sciences Transactions Service Sales Value Share by Region (2027-2032) Table 38. Global Life Sciences Transactions Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Life Sciences Transactions Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Life Sciences Transactions Service Sales Value Market Share by Country (2021-2026) Table 41. Global Life Sciences Transactions Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Life Sciences Transactions Service Sales Value Market Share by Country (2027-2032) Table 43. A&L Goodbody Company Information Table 44. A&L Goodbody Business Overview Table 45. A&L Goodbody Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. A&L Goodbody Life Sciences Transactions Service Product Portfolio Table 47. A&L Goodbody Recent Development Table 48. Arnold & Porter Company Information Table 49. Arnold & Porter Business Overview Table 50. Arnold & Porter Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Arnold & Porter Life Sciences Transactions Service Product Portfolio Table 52. Arnold & Porter Recent Development Table 53. Baker McKenzie Company Information Table 54. Baker McKenzie Business Overview Table 55. Baker McKenzie Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Baker McKenzie Life Sciences Transactions Service Product Portfolio Table 57. Baker McKenzie Recent Development Table 58. Covington Company Information Table 59. Covington Business Overview Table 60. Covington Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Covington Life Sciences Transactions Service Product Portfolio Table 62. Covington Recent Development Table 63. DLA Piper Company Information Table 64. DLA Piper Business Overview Table 65. DLA Piper Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. DLA Piper Life Sciences Transactions Service Product Portfolio Table 67. DLA Piper Recent Development Table 68. HaysMac Company Information Table 69. HaysMac Business Overview Table 70. HaysMac Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. HaysMac Life Sciences Transactions Service Product Portfolio Table 72. HaysMac Recent Development Table 73. Holland & Knight Company Information Table 74. Holland & Knight Business Overview Table 75. Holland & Knight Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Holland & Knight Life Sciences Transactions Service Product Portfolio Table 77. Holland & Knight Recent Development Table 78. Kirkland & Ellis LLP Company Information Table 79. Kirkland & Ellis LLP Business Overview Table 80. Kirkland & Ellis LLP Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Kirkland & Ellis LLP Life Sciences Transactions Service Product Portfolio Table 82. Kirkland & Ellis LLP Recent Development Table 83. L.E.K. Consulting Company Information Table 84. L.E.K. Consulting Business Overview Table 85. L.E.K. Consulting Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. L.E.K. Consulting Life Sciences Transactions Service Product Portfolio Table 87. L.E.K. Consulting Recent Development Table 88. Morgan Lewis Company Information Table 89. Morgan Lewis Business Overview Table 90. Morgan Lewis Life Sciences Transactions Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Morgan Lewis Life Sciences Transactions Service Product Portfolio Table 92. Morgan Lewis Recent Development Table 93. Osborne Clarke Company Information Table 94. Osborne Clarke Business Overview Table 95. Osborne Clarke Life Sciences Transactions Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Osborne Clarke Life Sciences Transactions Service Product Portfolio Table 97. Osborne Clarke Recent Development Table 98. Pharma Bio Source Company Information Table 99. Pharma Bio Source Business Overview Table 100. Pharma Bio Source Life Sciences Transactions Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Pharma Bio Source Life Sciences Transactions Service Product Portfolio Table 102. Pharma Bio Source Recent Development Table 103. Pinnacle Company Information Table 104. Pinnacle Business Overview Table 105. Pinnacle Life Sciences Transactions Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Pinnacle Life Sciences Transactions Service Product Portfolio Table 107. Pinnacle Recent Development Table 108. Reed Smith LLP Company Information Table 109. Reed Smith LLP Business Overview Table 110. Reed Smith LLP Life Sciences Transactions Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Reed Smith LLP Life Sciences Transactions Service Product Portfolio Table 112. Reed Smith LLP Recent Development Table 113. RNA Advisors Company Information Table 114. RNA Advisors Business Overview Table 115. RNA Advisors Life Sciences Transactions Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. RNA Advisors Life Sciences Transactions Service Product Portfolio Table 117. RNA Advisors Recent Development Table 118. Sidley Austin Company Information Table 119. Sidley Austin Business Overview Table 120. Sidley Austin Life Sciences Transactions Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Sidley Austin Life Sciences Transactions Service Product Portfolio Table 122. Sidley Austin Recent Development Table 123. Tenthpin Company Information Table 124. Tenthpin Business Overview Table 125. Tenthpin Life Sciences Transactions Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Tenthpin Life Sciences Transactions Service Product Portfolio Table 127. Tenthpin Recent Development Table 128. Troutman Pepper Locke Company Information Table 129. Troutman Pepper Locke Business Overview Table 130. Troutman Pepper Locke Life Sciences Transactions Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Troutman Pepper Locke Life Sciences Transactions Service Product Portfolio Table 132. Troutman Pepper Locke Recent Development Table 133. WilmerHale Company Information Table 134. WilmerHale Business Overview Table 135. WilmerHale Life Sciences Transactions Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. WilmerHale Life Sciences Transactions Service Product Portfolio Table 137. WilmerHale Recent Development Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Life Sciences Transactions Service Product Image Figure 2. Global Life Sciences Transactions Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Life Sciences Transactions Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Life Sciences Transactions Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Intellectual Property Licensing Transactions Image Figure 8. Product Asset Transactions Image Figure 9. Equity Mergers and Acquisitions Image Figure 10. Other Image Figure 11. Global Life Sciences Transactions Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Life Sciences Transactions Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Life Sciences Transactions Service Sales Value Share by Type (2021-2032) Figure 14. Biopharmaceuticals and Innovative Therapies Image Figure 15. Medical Devices and Diagnostics Image Figure 16. Contract Research, Development, and Manufacturing Organizations Image Figure 17. Digital Health and Healthcare Services Image Figure 18. Others Image Figure 19. Global Life Sciences Transactions Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Life Sciences Transactions Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Life Sciences Transactions Service Sales Value Share by Application (2021-2032) Figure 22. Global Life Sciences Transactions Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Life Sciences Transactions Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Life Sciences Transactions Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Life Sciences Transactions Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Life Sciences Transactions Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Life Sciences Transactions Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Life Sciences Transactions Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Life Sciences Transactions Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Life Sciences Transactions Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Life Sciences Transactions Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Life Sciences Transactions Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Life Sciences Transactions Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Life Sciences Transactions Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Intellectual Property Licensing Transactions
  • Product Asset Transactions
  • Equity Mergers and Acquisitions
  • Other
Applications
  • Biopharmaceuticals and Innovative Therapies
  • Medical Devices and Diagnostics
  • Contract Research, Development, and Manufacturing Organizations
  • Digital Health and Healthcare Services
  • Others
Companies covered
  • A&L Goodbody
  • Arnold & Porter
  • Baker McKenzie
  • Covington
  • DLA Piper
  • HaysMac
  • Holland & Knight
  • Kirkland & Ellis LLP
  • L.E.K. Consulting
  • Morgan Lewis
  • Osborne Clarke
  • Pharma Bio Source
  • Pinnacle
  • Reed Smith LLP
  • RNA Advisors
  • Sidley Austin
  • Tenthpin
  • Troutman Pepper Locke
  • WilmerHale

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Life Sciences Transactions Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Life Sciences Transactions Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Life Sciences Transactions Service Market Dynamics
  1. 2.1 Life Sciences Transactions Service Industry Trends
  2. 2.2 Life Sciences Transactions Service Industry Drivers
  3. 2.3 Life Sciences Transactions Service Industry Opportunities and Challenges
  4. 2.4 Life Sciences Transactions Service Industry Restraints
3 Life Sciences Transactions Service Market by Company
  1. 3.1 Global Life Sciences Transactions Service Company Revenue Ranking in 2025
  2. 3.2 Global Life Sciences Transactions Service Revenue by Company (2021-2026)
  3. 3.3 Global Life Sciences Transactions Service Company Ranking (2024-2026)
  4. 3.4 Global Life Sciences Transactions Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Life Sciences Transactions Service Company Product Type and Application
  6. 3.6 Global Life Sciences Transactions Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Life Sciences Transactions Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Life Sciences Transactions Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Life Sciences Transactions Service Market by Type
  1. 4.1 Life Sciences Transactions Service Type Introduction
  2. 4.1.1 Intellectual Property Licensing Transactions
  3. 4.1.2 Product Asset Transactions
  4. 4.1.3 Equity Mergers and Acquisitions
  5. 4.1.4 Other
  6. 4.2 Global Life Sciences Transactions Service Sales Value by Type
  7. 4.2.1 Global Life Sciences Transactions Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Life Sciences Transactions Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Life Sciences Transactions Service Sales Value Share by Type (2021-2032)
5 Life Sciences Transactions Service Market by Application
  1. 5.1 Life Sciences Transactions Service Application Introduction
  2. 5.1.1 Biopharmaceuticals and Innovative Therapies
  3. 5.1.2 Medical Devices and Diagnostics
  4. 5.1.3 Contract Research, Development, and Manufacturing Organizations
  5. 5.1.4 Digital Health and Healthcare Services
  6. 5.1.5 Others
  7. 5.2 Global Life Sciences Transactions Service Sales Value by Application
  8. 5.2.1 Global Life Sciences Transactions Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Life Sciences Transactions Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Life Sciences Transactions Service Sales Value Share by Application (2021-2032)
6 Life Sciences Transactions Service Regional Value Analysis
  1. 6.1 Global Life Sciences Transactions Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Life Sciences Transactions Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Life Sciences Transactions Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Life Sciences Transactions Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Life Sciences Transactions Service Sales Value (2021-2032)
  7. 6.3.2 North America Life Sciences Transactions Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Life Sciences Transactions Service Sales Value (2021-2032)
  10. 6.4.2 Europe Life Sciences Transactions Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Life Sciences Transactions Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Life Sciences Transactions Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Life Sciences Transactions Service Sales Value (2021-2032)
  16. 6.6.2 South America Life Sciences Transactions Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Life Sciences Transactions Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Life Sciences Transactions Service Sales Value Share by Country, 2025 VS 2032
7 Life Sciences Transactions Service Country-level Value Analysis
  1. 7.1 Global Life Sciences Transactions Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Life Sciences Transactions Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Life Sciences Transactions Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Life Sciences Transactions Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Life Sciences Transactions Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Life Sciences Transactions Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Life Sciences Transactions Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 A&L Goodbody
  2. 8.1.1 A&L Goodbody Company Information
  3. 8.1.2 A&L Goodbody Business Overview
  4. 8.1.3 A&L Goodbody Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 A&L Goodbody Life Sciences Transactions Service Product Portfolio
  6. 8.1.5 A&L Goodbody Recent Developments
  7. 8.2 Arnold & Porter
  8. 8.2.1 Arnold & Porter Company Information
  9. 8.2.2 Arnold & Porter Business Overview
  10. 8.2.3 Arnold & Porter Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Arnold & Porter Life Sciences Transactions Service Product Portfolio
  12. 8.2.5 Arnold & Porter Recent Developments
  13. 8.3 Baker McKenzie
  14. 8.3.1 Baker McKenzie Company Information
  15. 8.3.2 Baker McKenzie Business Overview
  16. 8.3.3 Baker McKenzie Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baker McKenzie Life Sciences Transactions Service Product Portfolio
  18. 8.3.5 Baker McKenzie Recent Developments
  19. 8.4 Covington
  20. 8.4.1 Covington Company Information
  21. 8.4.2 Covington Business Overview
  22. 8.4.3 Covington Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Covington Life Sciences Transactions Service Product Portfolio
  24. 8.4.5 Covington Recent Developments
  25. 8.5 DLA Piper
  26. 8.5.1 DLA Piper Company Information
  27. 8.5.2 DLA Piper Business Overview
  28. 8.5.3 DLA Piper Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DLA Piper Life Sciences Transactions Service Product Portfolio
  30. 8.5.5 DLA Piper Recent Developments
  31. 8.6 HaysMac
  32. 8.6.1 HaysMac Company Information
  33. 8.6.2 HaysMac Business Overview
  34. 8.6.3 HaysMac Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HaysMac Life Sciences Transactions Service Product Portfolio
  36. 8.6.5 HaysMac Recent Developments
  37. 8.7 Holland & Knight
  38. 8.7.1 Holland & Knight Company Information
  39. 8.7.2 Holland & Knight Business Overview
  40. 8.7.3 Holland & Knight Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Holland & Knight Life Sciences Transactions Service Product Portfolio
  42. 8.7.5 Holland & Knight Recent Developments
  43. 8.8 Kirkland & Ellis LLP
  44. 8.8.1 Kirkland & Ellis LLP Company Information
  45. 8.8.2 Kirkland & Ellis LLP Business Overview
  46. 8.8.3 Kirkland & Ellis LLP Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kirkland & Ellis LLP Life Sciences Transactions Service Product Portfolio
  48. 8.8.5 Kirkland & Ellis LLP Recent Developments
  49. 8.9 L.E.K. Consulting
  50. 8.9.1 L.E.K. Consulting Company Information
  51. 8.9.2 L.E.K. Consulting Business Overview
  52. 8.9.3 L.E.K. Consulting Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 L.E.K. Consulting Life Sciences Transactions Service Product Portfolio
  54. 8.9.5 L.E.K. Consulting Recent Developments
  55. 8.10 Morgan Lewis
  56. 8.10.1 Morgan Lewis Company Information
  57. 8.10.2 Morgan Lewis Business Overview
  58. 8.10.3 Morgan Lewis Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Morgan Lewis Life Sciences Transactions Service Product Portfolio
  60. 8.10.5 Morgan Lewis Recent Developments
  61. 8.11 Osborne Clarke
  62. 8.11.1 Osborne Clarke Company Information
  63. 8.11.2 Osborne Clarke Business Overview
  64. 8.11.3 Osborne Clarke Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Osborne Clarke Life Sciences Transactions Service Product Portfolio
  66. 8.11.5 Osborne Clarke Recent Developments
  67. 8.12 Pharma Bio Source
  68. 8.12.1 Pharma Bio Source Company Information
  69. 8.12.2 Pharma Bio Source Business Overview
  70. 8.12.3 Pharma Bio Source Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pharma Bio Source Life Sciences Transactions Service Product Portfolio
  72. 8.12.5 Pharma Bio Source Recent Developments
  73. 8.13 Pinnacle
  74. 8.13.1 Pinnacle Company Information
  75. 8.13.2 Pinnacle Business Overview
  76. 8.13.3 Pinnacle Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pinnacle Life Sciences Transactions Service Product Portfolio
  78. 8.13.5 Pinnacle Recent Developments
  79. 8.14 Reed Smith LLP
  80. 8.14.1 Reed Smith LLP Company Information
  81. 8.14.2 Reed Smith LLP Business Overview
  82. 8.14.3 Reed Smith LLP Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Reed Smith LLP Life Sciences Transactions Service Product Portfolio
  84. 8.14.5 Reed Smith LLP Recent Developments
  85. 8.15 RNA Advisors
  86. 8.15.1 RNA Advisors Company Information
  87. 8.15.2 RNA Advisors Business Overview
  88. 8.15.3 RNA Advisors Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 RNA Advisors Life Sciences Transactions Service Product Portfolio
  90. 8.15.5 RNA Advisors Recent Developments
  91. 8.16 Sidley Austin
  92. 8.16.1 Sidley Austin Company Information
  93. 8.16.2 Sidley Austin Business Overview
  94. 8.16.3 Sidley Austin Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sidley Austin Life Sciences Transactions Service Product Portfolio
  96. 8.16.5 Sidley Austin Recent Developments
  97. 8.17 Tenthpin
  98. 8.17.1 Tenthpin Company Information
  99. 8.17.2 Tenthpin Business Overview
  100. 8.17.3 Tenthpin Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Tenthpin Life Sciences Transactions Service Product Portfolio
  102. 8.17.5 Tenthpin Recent Developments
  103. 8.18 Troutman Pepper Locke
  104. 8.18.1 Troutman Pepper Locke Company Information
  105. 8.18.2 Troutman Pepper Locke Business Overview
  106. 8.18.3 Troutman Pepper Locke Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Troutman Pepper Locke Life Sciences Transactions Service Product Portfolio
  108. 8.18.5 Troutman Pepper Locke Recent Developments
  109. 8.19 WilmerHale
  110. 8.19.1 WilmerHale Company Information
  111. 8.19.2 WilmerHale Business Overview
  112. 8.19.3 WilmerHale Life Sciences Transactions Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 WilmerHale Life Sciences Transactions Service Product Portfolio
  114. 8.19.5 WilmerHale Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst